Aligos Therapeutics Inc (ALGS) Stock Price, Quote, News & History

ALGSNASDAQ
$5.04
-0.18-3.45%
At close: Sep 14, 5:00 PM EST
$5.20
0.163.17%
After Hours: Sep 11, 5:05 PM EST

Aligos Therapeutics (ALGS) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
$5.17
Close
$5.04
Volume / Avg.
28.02K / 165.00K
Day Range
$5.02 - $5.27
52 Wk Range
3.98 - 13.69
Market Cap
$32.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
12.22%
Days to Cover
9.41

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-94.17M
Investing Cash Flow (TTM)
105.59M
Financing Cash Flow (TTM)
228.00K
Free Cash Flow (TTM)
-94.52M
Capital Expenditure (TTM)
-355.00K
Net Change in Cash (TTM)
11.65M

Analyst Trends and Forecast

2
Mar
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$5.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1.73
PB Ratio (TTM)
1.03
Earnings Yield % (TTM)
-146.86%
Earnings Yield % (FWD)
-83.24%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.11

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$91.00K
Total Cash
$30.38M
Debt to Equity
0.11
Issuance of Debt (TTM)
-$91.00K
Repayment of Debt (TTM)
-$91.00K

Key Statistics

Open
$5.17
Close
$5.04
Volume / Avg.
28.02K / 165.00K
Day Range
$5.02 - $5.27
52 Wk Range
3.98 - 13.69
Market Cap
$32.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
36
Short Interest
12.22%
Days to Cover
9.41

About

Sector
Health Care
Industry
Biotechnology
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Aligos Therapeutics (ALGS) stock?

A

You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aligos Therapeutics (ALGS) competitors?

Q

What is the forecast, or price target, for Aligos Therapeutics (ALGS) stock?

A

Aligos Therapeutics has a consensus price target of $43.00.

Q

What is the current price for Aligos Therapeutics (ALGS)?

A

The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $5.2 last updated September 11, 2026 at 5:05 PM EDT.

Q

Does Aligos Therapeutics (ALGS) pay a dividend?

A

There are no upcoming dividends for Aligos Therapeutics.

Q

When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?

A

Aligos Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aligos Therapeutics (ALGS) going to split?

A

There is no upcoming split for Aligos Therapeutics.

Q

What sector and industry does Aligos Therapeutics (ALGS) operate in?

A

Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.